OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma
Stefano Fogli, Beatrice Polini, Sara Carpi, et al.
Tumor Biology (2017) Vol. 39, Iss. 5, pp. 101042831770164-101042831770164
Open Access | Times Cited: 57
Stefano Fogli, Beatrice Polini, Sara Carpi, et al.
Tumor Biology (2017) Vol. 39, Iss. 5, pp. 101042831770164-101042831770164
Open Access | Times Cited: 57
Showing 1-25 of 57 citing articles:
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
Atonu Chakrabortty, Daniel J. Patton, B. F. Smith, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1375-1375
Open Access | Times Cited: 108
Atonu Chakrabortty, Daniel J. Patton, B. F. Smith, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1375-1375
Open Access | Times Cited: 108
The role of miR-200 family in the regulation of hallmarks of cancer
Klaudia Klicka, Tomasz M. Grzywa, Aleksandra Mielniczuk, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 60
Klaudia Klicka, Tomasz M. Grzywa, Aleksandra Mielniczuk, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 60
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
Atonu Chakrabortty, Daniel J. Patton, B. F. Smith, et al.
(2023)
Open Access | Times Cited: 30
Atonu Chakrabortty, Daniel J. Patton, B. F. Smith, et al.
(2023)
Open Access | Times Cited: 30
Emerging biomarkers for non-invasive diagnosis and treatment of cancer: a systematic review
Suleiman Zakari, Nguedia K. Niels, Grace V. Olagunju, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 11
Suleiman Zakari, Nguedia K. Niels, Grace V. Olagunju, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 11
Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine
Sophie Mumford, Benjamin P. Towler, Amy L. Pashler, et al.
Biomolecules (2018) Vol. 8, Iss. 2, pp. 21-21
Open Access | Times Cited: 73
Sophie Mumford, Benjamin P. Towler, Amy L. Pashler, et al.
Biomolecules (2018) Vol. 8, Iss. 2, pp. 21-21
Open Access | Times Cited: 73
Prognostic and Predictive Epigenetic Biomarkers in Oncology
Katarzyna H. Kaminska, Ewelina Nalejska, Marta Kubiak, et al.
Molecular Diagnosis & Therapy (2018) Vol. 23, Iss. 1, pp. 83-95
Open Access | Times Cited: 71
Katarzyna H. Kaminska, Ewelina Nalejska, Marta Kubiak, et al.
Molecular Diagnosis & Therapy (2018) Vol. 23, Iss. 1, pp. 83-95
Open Access | Times Cited: 71
miR-149 in Human Cancer: A Systemic Review
Yunjie He, Dandan Yu, Lingping Zhu, et al.
Journal of Cancer (2017) Vol. 9, Iss. 2, pp. 375-388
Open Access | Times Cited: 66
Yunjie He, Dandan Yu, Lingping Zhu, et al.
Journal of Cancer (2017) Vol. 9, Iss. 2, pp. 375-388
Open Access | Times Cited: 66
Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
Alessia Finotti, Matteo Allegretti, Jessica Gasparello, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 65
Alessia Finotti, Matteo Allegretti, Jessica Gasparello, et al.
International Journal of Oncology (2018)
Open Access | Times Cited: 65
Melanoma: Where we are and where we go
Ali Mohammadpour, Maryam Derakhshan, Hassan Darabi, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 4, pp. 3307-3320
Closed Access | Times Cited: 61
Ali Mohammadpour, Maryam Derakhshan, Hassan Darabi, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 4, pp. 3307-3320
Closed Access | Times Cited: 61
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
Luigi Fattore, Ciro Francesco Ruggiero, Maria Elena Pisanu, et al.
Cell Death and Differentiation (2018) Vol. 26, Iss. 7, pp. 1267-1282
Open Access | Times Cited: 60
Luigi Fattore, Ciro Francesco Ruggiero, Maria Elena Pisanu, et al.
Cell Death and Differentiation (2018) Vol. 26, Iss. 7, pp. 1267-1282
Open Access | Times Cited: 60
MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
Soudeh Ghafouri‐Fard, Mahdi Gholipour, Mohammad Taheri
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
Soudeh Ghafouri‐Fard, Mahdi Gholipour, Mohammad Taheri
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection—Narrative Review
Agata Poniewierska-Baran, Łukasz Zadroga, Edo Danilyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5386-5386
Open Access | Times Cited: 17
Agata Poniewierska-Baran, Łukasz Zadroga, Edo Danilyan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5386-5386
Open Access | Times Cited: 17
Circulating miRNAs as biomarkers for the diagnosis in patients with melanoma: systematic review and meta-analysis
Nicholas Jones, T. NONAKA
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 6
Nicholas Jones, T. NONAKA
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 6
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer
Giorgio Durante, Elisabetta Broseghini, Francesca Comito, et al.
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 3, pp. 305-318
Closed Access | Times Cited: 25
Giorgio Durante, Elisabetta Broseghini, Francesca Comito, et al.
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 3, pp. 305-318
Closed Access | Times Cited: 25
Interplay between small and long non‐coding RNA s in cutaneous melanoma: a complex jigsaw puzzle with missing pieces
Mattia Riefolo, Elisa Porcellini, Emi Dika, et al.
Molecular Oncology (2018) Vol. 13, Iss. 1, pp. 74-98
Open Access | Times Cited: 39
Mattia Riefolo, Elisa Porcellini, Emi Dika, et al.
Molecular Oncology (2018) Vol. 13, Iss. 1, pp. 74-98
Open Access | Times Cited: 39
The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies
Lorena Quirico, Francesca Orso
Cancer Drug Resistance (2020)
Open Access | Times Cited: 39
Lorena Quirico, Francesca Orso
Cancer Drug Resistance (2020)
Open Access | Times Cited: 39
Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis
Nan Wu, Hongyan Sun, Qian Sun, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Nan Wu, Hongyan Sun, Qian Sun, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Liquid biopsy for diagnostic and prognostic evaluation of melanoma
Nicholas Slusher, Nicholas Jones, T. NONAKA
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Nicholas Slusher, Nicholas Jones, T. NONAKA
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Circulating MicroRNAs: functional biomarkers for melanoma prognosis and treatment
Su Yin Lim, Suzanah C. Boyd, Russell J. Diefenbach, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Su Yin Lim, Suzanah C. Boyd, Russell J. Diefenbach, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Exosomal Biomarkers: A Comprehensive Overview of Diagnostic and Prognostic Applications in Malignant and Non-Malignant Disorders
Mahda Delshad, Mohammad‐Javad Sanaei, Mohammad Hossein Mohammadi, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 587-587
Open Access
Mahda Delshad, Mohammad‐Javad Sanaei, Mohammad Hossein Mohammadi, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 587-587
Open Access
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells
Arianna Bellazzo, Giulio Di Minin, Elena Valentino, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 7, pp. 1224-1238
Open Access | Times Cited: 36
Arianna Bellazzo, Giulio Di Minin, Elena Valentino, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 7, pp. 1224-1238
Open Access | Times Cited: 36
Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment
Qiang Ye, Zi Li, Yang Li, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 80-80
Open Access | Times Cited: 17
Qiang Ye, Zi Li, Yang Li, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 80-80
Open Access | Times Cited: 17
Differences in the miRNA signatures of chronic musculoskeletal pain patients from neuropathic or nociceptive origins
Camille Florine Dayer, François Lüthi, Joane Le Carré, et al.
PLoS ONE (2019) Vol. 14, Iss. 7, pp. e0219311-e0219311
Open Access | Times Cited: 29
Camille Florine Dayer, François Lüthi, Joane Le Carré, et al.
PLoS ONE (2019) Vol. 14, Iss. 7, pp. e0219311-e0219311
Open Access | Times Cited: 29
miRNAs as Key Players in the Management of Cutaneous Melanoma
Celeste Lorusso, Simona De Summa, Rosamaria Pinto, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 415-415
Open Access | Times Cited: 26
Celeste Lorusso, Simona De Summa, Rosamaria Pinto, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 415-415
Open Access | Times Cited: 26
Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis
Matías A. Bustos, Kevin Tran, Negin Rahimzadeh, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1692-1692
Open Access | Times Cited: 24
Matías A. Bustos, Kevin Tran, Negin Rahimzadeh, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1692-1692
Open Access | Times Cited: 24
